Ligand Pharmaceuticals Incorporated

NASDAQ (USD): Ligand Pharmaceuticals Incorporated (LGND)

Last Price

84.37

Today's Change

+1.67 (2.009%)

Day's Change

81.75 - 84.53

Trading Volume

54,808

Financial

Reported Currency in USD
Show?
Last 10 FY Result (Thousand)
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 131,314 196,245 277,133 186,419 120,282 251,453 141,102 108,973 71,914 64,538 8.20%
PBT 63,660 36,011 47,298 -10,538 796,639 173,330 57,231 7,960 35,329 11,302 21.16%
Tax 9,841 41,230 -10,288 -7,553 167,337 30,009 44,675 10,327 -219,596 410 42.32%
NP 52,154 -5,219 57,138 -2,985 629,302 143,321 12,556 -1,636 257,305 12,024 17.69%
Tax Rate -15.46% -114.49% 21.75% - -21.01% -17.31% -78.06% -129.74% 621.57% -3.63% -
Total Cost 79,160 201,464 219,995 189,404 -509,020 108,132 128,546 110,609 -185,391 52,514 4.66%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 39.72 -2.66 20.62 -1.60 523.19 57.00 8.90 -1.50 357.80 18.63 8.77%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 3.02 -0.31 3.44 -0.18 33.13 5.96 0.60 -0.08 13.00 0.59 19.88%
EPS Diluted 2.94 -0.31 3.31 -0.18 31.85 5.96 0.53 -0.08 12.12 0.56 20.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ & YoY figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment